Foracort 400 Inhaler is a clinically trusted combination inhaler designed for the long-term management of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Manufactured by Cipla, this inhaler delivers a precise blend of Budesonide and Formoterol Fumarate to support improved breathing and enhanced quality of life when used as directed by a healthcare professional.
Asthma and COPD are chronic respiratory disorders characterized by airway inflammation, narrowing, and obstruction. These conditions often result in symptoms such as breathlessness, wheezing, chest tightness, and persistent coughing. Foracort 400 Inhaler works through a dual-action mechanism that addresses both inflammation and airway constriction, offering comprehensive respiratory care.
Budesonide, an inhaled corticosteroid, reduces inflammation, swelling, and irritation within the airways. By targeting the underlying inflammatory processes, it helps maintain airway stability and prevents symptom exacerbations. Formoterol Fumarate, a long-acting beta-2 agonist (LABA), relaxes the smooth muscles surrounding the airways, enabling them to remain open for extended periods. This synergistic combination ensures sustained bronchodilation and improved airflow.
The inhaler provides 120 metered doses, delivering accurate and consistent amounts of medication with each actuation. Its integrated dose counter enables users to monitor remaining doses easily, ensuring timely refills and uninterrupted therapy. This feature enhances treatment adherence and promotes effective long-term disease management.
Foracort 400 Inhaler is typically prescribed for maintenance therapy rather than emergency relief. It is not intended for the treatment of sudden asthma attacks; therefore, patients should keep a fast-acting rescue inhaler available for acute symptoms, as advised by their physician.
The compact and portable design ensures convenience for daily use at home, work, or while traveling. Cipla’s stringent manufacturing standards guarantee the product’s safety, quality, and efficacy, making it a preferred choice among healthcare professionals worldwide.
Proper inhalation technique is essential for optimal therapeutic benefits. Users are advised to follow their doctor’s instructions carefully and refer to the patient information leaflet included with the product. Rinsing the mouth after each use helps reduce the risk of oral fungal infections associated with inhaled corticosteroids.
This prescription-only medication should be used strictly under medical supervision. Patients with existing medical conditions, pregnant or breastfeeding women, and those taking other medications should consult their healthcare provider before use.
Foracort 400 Inhaler offers a reliable and effective solution for managing chronic respiratory conditions. With its dual-action formula, precise dosing system, and trusted Cipla quality, it plays a vital role in supporting long-term respiratory health and overall well-being.